High density is a property of slow‐cycling and treatment‐resistant human glioblastoma cells
暂无分享,去创建一个
M. Berger | C. James | D. Quigley | J. Phillips | H. Sabelström | A. Persson | Nan Li | T. Fenster | David C. James | Daniel J. Foster | E. Yuan | Supna Saxena | Clara A M Fuchshuber | Francesca Paterno | Börje Norling
[1] S. Stylli,et al. Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance , 2019, Experimental cell research.
[2] T. Garrett,et al. Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma , 2018, The EMBO journal.
[3] J. Tabernero,et al. A slow-cycling Lgr5 tumour population mediates basal cell carcinoma relapse after therapy , 2018, Nature.
[4] J. Tabernero,et al. TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence , 2018, The Journal of clinical investigation.
[5] Ji-Yong Um,et al. Human glioblastoma arises from subventricular zone cells with low-level driver mutations , 2018, Nature.
[6] Richard A. Moore,et al. Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy , 2017, Nature.
[7] Shawn M. Gillespie,et al. Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance. , 2017, Cell stem cell.
[8] J. García-Verdugo,et al. Implications of irradiating the subventricular zone stem cell niche. , 2016, Stem cell research.
[9] Thomas C. Chen,et al. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. , 2015, JAMA.
[10] Xin Chen,et al. Cancer stem cells and cell size: A causal link? , 2015, Seminars in cancer biology.
[11] F. Parodi,et al. The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma , 2015, Cell cycle.
[12] Enric Llorens-Bobadilla,et al. Single-Cell Transcriptomics Reveals a Population of Dormant Neural Stem Cells that Become Activated upon Brain Injury. , 2015, Cell stem cell.
[13] J. Rich,et al. Cancer stem cells in glioblastoma , 2015, Genes & development.
[14] K. Ichimura,et al. Revisiting TP53 Mutations and Immunohistochemistry—A Comparative Study in 157 Diffuse Gliomas , 2015, Brain pathology.
[15] C. Collins,et al. The epigenetic/noncoding origin of tumor dormancy. , 2015, Trends in molecular medicine.
[16] Aaron A. Cohen-Gadol,et al. Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs , 2015, Genes & diseases.
[17] Dustin J Maly,et al. Radiotherapy Followed by Aurora Kinase Inhibition Targets Tumor-Propagating Cells in Human Glioblastoma , 2014, Molecular Cancer Therapeutics.
[18] N. Grabe,et al. Aberrant self‐renewal and quiescence contribute to the aggressiveness of glioblastoma , 2014, The Journal of pathology.
[19] Shawn M. Gillespie,et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma , 2014, Science.
[20] Erika Pastrana,et al. Prospective Identification and Purification of Quiescent Adult Neural Stem Cells from Their In Vivo Niche , 2014, Neuron.
[21] Melinda J. Cromie,et al. mTORC1 controls the adaptive transition of quiescent stem cells from G0 to GAlert , 2014, Nature.
[22] Simon Kasif,et al. Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells , 2014, Cell.
[23] Amy Brock,et al. Non-Darwinian dynamics in therapy-induced cancer drug resistance , 2013, Nature Communications.
[24] Se Hoon Kim,et al. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. , 2013, Cancer cell.
[25] L. Gauthier,et al. Quiescent neural stem cells exit dormancy upon alteration of GABAAR signaling following radiation damage. , 2013, Stem cell research.
[26] P. Gimotty,et al. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells. , 2013, Cancer cell.
[27] P. Benos,et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3 , 2013, Proceedings of the National Academy of Sciences.
[28] I. Weissman,et al. Brain Tumor Stem Cell Multipotency Correlates with Nanog Expression and Extent of Passaging in Human Glioblastoma Xenografts , 2013, Oncotarget.
[29] J. García-Verdugo,et al. Subventricular Zone Localized Irradiation Affects the Generation of Proliferating Neural Precursor Cells and the Migration of Neuroblasts , 2012, Stem cells.
[30] Sungmin Son,et al. Direct observation of mammalian cell growth and size regulation , 2012, Nature Methods.
[31] Tzong-Shiue Yu,et al. A restricted cell population propagates glioblastoma growth following chemotherapy , 2012, Nature.
[32] K. Dou,et al. Efficient Enrichment of Hepatic Cancer Stem-Like Cells from a Primary Rat HCC Model via a Density Gradient Centrifugation-Centered Method , 2012, PloS one.
[33] Zhihui Liu,et al. Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas. , 2011, Oncology reports.
[34] A. Lee,et al. Biophysical Characteristics Reveal Neural Stem Cell Differentiation Potential , 2011, PloS one.
[35] Clinton C. Dawson,et al. “Persisters”: Survival at the Cellular Level , 2011, PLoS pathogens.
[36] A. Vescovi,et al. Evidence for label-retaining tumour-initiating cells in human glioblastoma. , 2011, Brain : a journal of neurology.
[37] J. Baselga,et al. TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. , 2010, Cancer cell.
[38] C. Zimmer,et al. Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. , 2010, Neuro-oncology.
[39] Rafael A. Irizarry,et al. A framework for oligonucleotide microarray preprocessing , 2010, Bioinform..
[40] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[41] D. Figarella-Branger,et al. A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties , 2010, Brain pathology.
[42] M. Kirschner,et al. Cell Growth and Size Homeostasis in Proliferating Animal Cells , 2009, Science.
[43] A. Aspán,et al. Flotation—A New Method to Circumvent PCR Inhibitors in the Diagnosis of Lawsonia intracellularis , 2009, International journal of microbiology.
[44] Mark Bernstein,et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. , 2009, Cell stem cell.
[45] H. Kettenmann,et al. Enriched Monolayer Precursor Cell Cultures from Micro-Dissected Adult Mouse Dentate Gyrus Yield Functional Granule Cell-Like Neurons , 2007, PloS one.
[46] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[47] Yuri Kotliarov,et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.
[48] David J. Yang,et al. Innate immune functions of microglia isolated from human glioma patients , 2006, Journal of Translational Medicine.
[49] Martin Kuiper,et al. BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks , 2005, Bioinform..
[50] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[51] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[52] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[53] Christine Brun,et al. In silico prediction of protein-protein interactions in human macrophages , 2001, BMC Research Notes.
[54] T. Palmer,et al. Fibroblast Growth Factor-2 Activates a Latent Neurogenic Program in Neural Stem Cells from Diverse Regions of the Adult CNS , 1999, The Journal of Neuroscience.
[55] I. Parney,et al. Improved Technique for Establishing Short Term Human Brain Tumor Cultures , 1999, Journal of Neuro-Oncology.
[56] A. Hamberger,et al. Glial cell characteristics in bulk-prepared cell fractions from human brain tumours , 1977, Acta Neuropathologica.
[57] A. Falini,et al. Cancer esearch cular and Cellular Pathobiology ermal Growth Factor Receptor Expression Identifies ctionally and Molecularly Distinct Tumor-Initiating Cells uman Glioblastoma Multiforme and Is Required R Gliomagenesis , 2010 .
[58] P. Rieckmann,et al. Isolation and Culture of Microvascular Endothelial Cells from Gliomas of Different WHO Grades , 2005, Journal of Neuro-Oncology.